RxDoctor Payments Data

Aggy Vallanat

Psychiatry · Jamaica, NYNPI 1417033481

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $908 of the $1,158 with a category attached, or 78.4%. Every reported general payment came from a single manufacturer, Avanir Pharmaceuticals, Inc..

$1,158in general payments, 2019–2025

Across 9 payments — averaging $128.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$1K
$833,179in research payments, 2019–2025

Across 313 payments — averaging $2661.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$195K
  • AbbVie$141K
  • Boehringer Ingelheim$111K
  • Alkermes, Inc.$108K
  • Takeda Pharmaceuticals U.S.A., Inc.$58K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48K
  • plus $173K from 10 others

What the payments were for

  • Travel & lodging$90878%
  • Food & beverage$25022%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Avanir Pharmaceuticals, Inc.9$1,158

How this compares

$1,158 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Other psychiatry in Jamaica

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →